Hapoalim Securities

Hapoalim Securities is maintaining its Hold rating on shares of SunPower Corporation (NASDAQ: SPWRA). “Though disclosures in its 2010 10K offered nothing to alter our thesis on SPWRA, it offered some useful insight into (1) the extent to which non‐module components drive revenue, (2) coming cash...

Hapoalim Securities is out with its report on The Kroger Company (NYSE: KR), raising its price target from $17 to $19. In the report, Hapoalim writes "KR's 4Q ID sales (ex. fuel) came in better than expected at 3.8% (vs. our est. of 2.5%) with gross margin reflecting some stabilization based on Y/Y...

Hapoalim is out with a research report on First Solar (NASDAQ: FSLR), and it has a Sell rating and a $125 price target. In a note to clients, Hapoalim writes, "While no major surprises emerged from FSLR's 10K, detail was provided on some key aspects of FSLR's business. Notable disclosures included...

Hapoalim Securities maintained its First Solar (NASDAQ: FSLR) Sell rating and $125 price target in a research report published today. In the report, Hapoalim Securities states, "While no major surprises emerged from FSLR's 10K, detail was provided on some key aspects of FSLR's business. Notable...

Hapoalim Securities is raising its PT on shares of First Solar, Inc. (NASDAQ: FSLR) to $125. Hapoalim Securities is maintaining it Sell rating, however. First Solar closed Thursday at $164.68.

Hapoalim Securities is raising its PT on shares of Trina Solar Limited (NYSE: TSL) from $27 to $30. “As we believe TSL stands out from its peers due to (1) defensive margins, (2) a disciplined capital spending strategy, and (3) free cash flow generation, we view it as a preferred vehicle for solar...

Hapoalim Securities maintained its Trina Solar (NYSE: TSL) Hold rating and raised Trina Solar's price target from $27 to $30 in a research report published today. In the report, Hapoalim Securities states, "As we believe TSL stands out from its peers due to (1) defensive margins, (2) a disciplined...

Hapoalim Securities maintained its Trina Solar (NYSE: TSL) Hold rating in a research report published today. Hapoalim Securities has previously given Trina Solar a $27 price target. In the report, Hapoalim Securities states, "While we prefer TSL over its peers for exposure to the solar...

Hapoalim Securities is out with a report previewing First Solar, Inc. (NASDAQ: FSLR) earnings report. It has a Sell rating and a $110 price target on shares. In a note to clients, Hapoalim writes, "Consistent with the rest of the broader solar industry, we expect strong year-end demand and higher...

Hapoalim Securities is maintaining its Sell rating, but is raising its price target to $10 from $9 on shares of Yingli Green Energy Hold. Co. Ltd. (NYSE: YGE). In a note to clients, Hapoalim writes, "With ASPs up 4% in the quarter to around $1.74/watt and offsetting an increase in cost/watt of $0....

Hapoalim Securities maintained its Yingli Green Energy (NYSE: YGE) Sell rating and $9 price target in a research report published today. In the report, Hapoalim Securities states, "Demonstrating the healthy operating environment for the solar industry in the final quarter of 2010, YGE reported 4Q10...

Hapoalim Securities kept its Sunpower (NASDAQ: SPWRA) Hold rating and $14 price target in a research report published today. In the report, Hapoalim Securities states, "Rounding out a back-end loaded year that had sparked some doubts, SPWRA did not disappoint, as large project sales, better-than-...

With earnings season under way for the solar industry, Hapoalim Securities is offering a 4Q10 preview for Suntech Power Holdings Co. Ltd. (NYSE: STP), Trina Solar Ltd. (NYSE: TSL), and Yingli Green Energy Holding Co. Ltd. (NYSE: YGE). “While we believe strong 4Q10 results are widely expected—buoyed...

Hapoalim Securities has a Hold rating on shares of Neurocrine Biosciences, Inc. (NASDAQ: NBIX), and sees strong upside in shares, with an $11 price target. In a note to clients, Hapoalim writes, "An end of Phase 2 meeting with the FDA for elagolix is scheduled to occur in March 2011 and Neurocrine...

Hapoalim Securities is raising its PT on shares of Targacept, Inc. (NASDAQ: TRGT) to $28 from $25.